AIMS/HYPOTHESIS: The aim of this study was to estimate absolute and relative mortality rates in patients with type 1 diabetes at the Steno Diabetes Centre relative to the general Danish background population. METHODS: Patients with type 1 diabetes (n = 4,821) were followed from 1 January 2002 until 1 January 2011, with death from any cause as the main outcome. Poisson regression was used to model mortality rates by age, diabetes duration and calendar time, according to sex. RESULTS: In the period 2002-2010, a total of 673 deaths (402 men, 271 women) occurred in the study population during 33,847 years of follow-up of type 1 diabetes. The predominant cause of death in patients with type 1 diabetes was cardiovascular disease. Mortality rates were highest among those with the lowest age at onset, particularly men. The mortality rate in the diabetic population decreased over that time period by 6.6% and 4.8% per year in men and women, respectively; this was substantially greater than the decrease in mortality rates in the background population. The decline in standard mortality rate was 4.3% per year in men and 2.6% per year in women. Patients who did not develop nephropathy had only slightly elevated mortality rates compared with the background population. CONCLUSIONS/ INTERPRETATION: Despite advances in care, mortality rates in the past decade continue to be greater in patients with type 1 diabetes than in those without diabetes; however, the mortality rate in patients decreased over the study period faster than that of the background population. Nephropathy seems to be the main driver of the excess mortality.
AIMS/HYPOTHESIS: The aim of this study was to estimate absolute and relative mortality rates in patients with type 1 diabetes at the Steno Diabetes Centre relative to the general Danish background population. METHODS:Patients with type 1 diabetes (n = 4,821) were followed from 1 January 2002 until 1 January 2011, with death from any cause as the main outcome. Poisson regression was used to model mortality rates by age, diabetes duration and calendar time, according to sex. RESULTS: In the period 2002-2010, a total of 673 deaths (402 men, 271 women) occurred in the study population during 33,847 years of follow-up of type 1 diabetes. The predominant cause of death in patients with type 1 diabetes was cardiovascular disease. Mortality rates were highest among those with the lowest age at onset, particularly men. The mortality rate in the diabetic population decreased over that time period by 6.6% and 4.8% per year in men and women, respectively; this was substantially greater than the decrease in mortality rates in the background population. The decline in standard mortality rate was 4.3% per year in men and 2.6% per year in women. Patients who did not develop nephropathy had only slightly elevated mortality rates compared with the background population. CONCLUSIONS/ INTERPRETATION: Despite advances in care, mortality rates in the past decade continue to be greater in patients with type 1 diabetes than in those without diabetes; however, the mortality rate in patients decreased over the study period faster than that of the background population. Nephropathy seems to be the main driver of the excess mortality.
Authors: S S Soedamah-Muthu; J H Fuller; H E Mulnier; V S Raleigh; R A Lawrenson; H M Colhoun Journal: Diabetologia Date: 2006-01-24 Impact factor: 10.122
Authors: I Waernbaum; G Blohmé; J Ostman; G Sundkvist; J W Eriksson; H J Arnqvist; J Bolinder; L Nyström Journal: Diabetologia Date: 2006-01-31 Impact factor: 10.122
Authors: Sabin Allemann; Christoph Saner; Marcel Zwahlen; Emanuel R Christ; Peter Diem; Christoph Stettler Journal: Swiss Med Wkly Date: 2009-10-03 Impact factor: 2.193
Authors: C C Patterson; G Dahlquist; V Harjutsalo; G Joner; R G Feltbower; J Svensson; E Schober; E Gyürüs; C Castell; B Urbonaité; J Rosenbauer; V Iotova; A V Thorsson; G Soltész Journal: Diabetologia Date: 2007-09-28 Impact factor: 10.122
Authors: Shona J Livingstone; Helen C Looker; Eleanor J Hothersall; Sarah H Wild; Robert S Lindsay; John Chalmers; Stephen Cleland; Graham P Leese; John McKnight; Andrew D Morris; Donald W M Pearson; Norman R Peden; John R Petrie; Sam Philip; Naveed Sattar; Frank Sullivan; Helen M Colhoun Journal: PLoS Med Date: 2012-10-02 Impact factor: 11.069
Authors: Per-Henrik Groop; Merlin C Thomas; John L Moran; Johan Wadèn; Lena M Thorn; Ville-Petteri Mäkinen; Milla Rosengård-Bärlund; Markku Saraheimo; Kustaa Hietala; Outi Heikkilä; Carol Forsblom Journal: Diabetes Date: 2009-04-28 Impact factor: 9.461
Authors: Dennis Petrie; Tom W C Lung; Aidin Rawshani; Andrew J Palmer; Ann-Marie Svensson; Björn Eliasson; Philip Clarke Journal: Diabetologia Date: 2016-04-05 Impact factor: 10.122
Authors: Julie A Lovshin; Marko Škrtić; Petter Bjornstad; Rahim Moineddin; Denis Daneman; David Dunger; Heather N Reich; Farid Mahmud; James Scholey; David Z I Cherney; Etienne Sochett Journal: Am J Physiol Renal Physiol Date: 2017-12-13
Authors: Shona J Livingstone; Daniel Levin; Helen C Looker; Robert S Lindsay; Sarah H Wild; Nicola Joss; Graham Leese; Peter Leslie; Rory J McCrimmon; Wendy Metcalfe; John A McKnight; Andrew D Morris; Donald W M Pearson; John R Petrie; Sam Philip; Naveed A Sattar; Jamie P Traynor; Helen M Colhoun Journal: JAMA Date: 2015-01-06 Impact factor: 56.272